Major Depressive Disorder patients display a reduced ability to feel pleasant experiences known as Anhedonia. Such a feature provides difficulties when treating depression and engaging patients during clinical trials.
Michele Garibbo
Advertisement
Articles by Michele Garibbo
Advertisement
Latest Updated Articles
Leverage Site-Owned Tech to Improve Trial RetentionApril 25th 2016
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Agentic RTSM and the Push to Compress Clinical Trial Startup: Q&A with Robert Hummel, Suvoda
2
AI-Driven Clinical Trial Recruitment and Design
3
Why Clinical Trials Need an Execution Architecture Before AI Can Deliver: Q&A with Abraham Gutman, AG Mednet
4
ACT Brief: Quality Built Throughout Trial Lifecycle, Agentic RTSM Compression, and State Access Programs
5